ArticleAging and disease2021

Mesenchymal Stem Cells for the Compassionate Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID 19.

Martin Iglesias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.